Professor Nicholas Turner is a Consultant Medical Oncologist who specialises in the treatment of breast cancer. He read Natural Sciences at Cambridge University before qualifying in 1997 from the University of Oxford Medical School. After completing general medical training in London, he trained in medical oncology at Royal Free and University College Hospitals and completed a PhD at The Institute of Cancer Research in 2006. He joined the Breast Unit of The Royal Marsden as a Consultant in Medical Oncology in 2008.
He is a Team Leader in Molecular Oncology at the Breast Cancer Now Research Centre at the Institute of Cancer Research (ICR). He is Genotyping, Phenotyping and Cancer Evolution Theme Lead for The Royal Marsden and ICR NIHR Biomedical Research Centre.
Professor Turner is the Breast Domain Lead of the Genomics England Clinical Interpretation Partnerships, and has co-chaired of the ASCO/CAP review committee on circulating tumor DNA analysis in patients with cancer. He sits on the organising committees of many international conferences on breast cancer, was the executive chair of the IMPAKT 2015 breast cancer conference, and is a scientific editor of the journal Cancer Discovery. He is Chief Investigator of a number of national and international trials of precision therapy in breast cancer. His research interests include the development of new therapies for breast cancer and using liquid biopsies to deliver more precise treatment for breast cancer.